Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process

Virology

Volumn 284, Issue 1, 2001, Pages 26-36

  Sun, Jiangfeng ^a,b   Barbeau, Benoit ^a,b   Sato, Sachiko ^a,b   Tremblay, Michel J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

AIDS HIV; Cell to cell interactions; Human

Indexed keywords

BACTERIAL ENZYME; CD4 ANTIGEN; CHEMOKINE RECEPTOR; GLYCOCONJUGATE; GLYCOPROTEIN GP 120; SIALIC ACID; SIALIDASE;

ARTHROBACTER; ARTICLE; BACTERIUM; CELL INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MURINE LEUKEMIA VIRUS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; SYNCYTIUM; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION;

AMPHOTROPIC MURINE LEUKEMIA VIRUS; ARTHROBACTER UREAFACIENS; BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 0035947107     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0889     Document Type: Article

References (40)

1. Acheson A., Sunshine J. L., Rutishauser U. NCAM polysialic acid can regulate both cell-cell and cell-substrate interactions. J. Cell Biol. 114:1991;143-153.
2. Aguilar-Cordova E., Chinen J., Donehower L., Lewis D. E., Belmont J. W. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses. 10:1994;295-301.
3. Barbeau B., Fortin J. F., Genois N., Tremblay M. J. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay. J. Virol. 72:1998;7125-7136.
4. Bérubé P., Barbeau B., Cantin R., Sekaly R. P., Tremblay M. Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 70:1996;4009-4016.
5. Cantin R., Fortin J. F., Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. 218:1996;372-381.
6. Chen B. K., Saksela K., Andino R., Baltimore D. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:1994;654-660.
7. Dimitrov D. S., Willey R. L., Sato H., Chang L. J., Blumenthal R., Martin M. A. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:1993;2182-2190.
8. Fortin J. F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:1997;3588-3596.
9. Gelderblom H. R., Reupke H., Pauli G. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet. 2:1985;1016-1017.
10. Genois N., Robichaud G. A., Tremblay M. J. Mono Mac 1: A new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series. J. Leukocyte Biol. 68:2000;854-864.
11. Graziosi C., Soudeyns H., Rizzardi G. P., Bart P. A., Chapuis A., Pantaleo G. Immunopathogenesis of HIV infection. AIDS Res. Hum. Retroviruses. 14:1998;S135-S142.
12. Henderson A. J., Zou X., Calame K. L. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:1995;5337-5344.
13. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell. Dev. Biol. 12:1996;627-661.
14. Horuk R. Chemokine receptors and HIV-1: The fusion of two major research fields. Immunol. Today. 20:1999;89-94.
15. Hu H., Shioda T., Moriya C., Xin X., Hasan M. K., Miyake K., Shimada T., Nagai Y. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J. Virol. 70:1996;7462-7470.
16. Keppler O. T., Hinderlich S., Langner J., Schwartz-Albiez R., Reutter W., Pawlita M. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation. Science. 284:1999;1372-1376.
17. Layne S. P., Merges M. J., Dembo M., Spouge J. L., Nara P. L. HIV requires multiple gp120 molecules for CD4-mediated infection. Nature. 346:1990;277-279.
18. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steimer K. S., Engleman E. G. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature. 323:1986a;725-728.
19. Lifson J. D., Reyes G. R., McGrath M. S., Stein B. S., Engleman E. G. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science. 232:1986b;1123-1127.
20. + cell line H9. AIDS Res. Hum. Retroviruses. 5:1989;253-255.
21. Maréchal V., Clavel F., Heard J. M., Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:1998;2208-2212.
22. Matlin K. S., Reggio H., Helenius A., Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:1982;609-631.
23. McKeating J. A., McKnight A., Moore J. P. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization. J. Virol. 65:1991;852-860.
24. Means R. B., Desrosiers R. C. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J. Virol. 74:2000;11181-11190.
25. Neuzil K. M., Reed G. W., Mitchel E. F. Jr., Griffin M. R. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 281:1999;901-907.
26. Pantaleo G., Graziosi C., Butini L., Pizzo P. A., Schnittman S. M., Kotler D. P., Fauci A. S. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 88:1991;9838-9842.
27. Paquette J. S., Fortin J. F., Blanchard L., Tremblay M. J. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J. Virol. 72:1998;9329-9336.
28. + mobilization after CD3 stimulation. J. Immunol. 147:1991;3145-3148.
29. Poli G., Pantaleo G., Fauci A. S. Immunopathogenesis of human immunodeficiency virus infection. Clin. Infect. Dis. 17:1993;S224-S229.
30. Roggentin P., Gutschker-Gdaniec G. H., Hobrecht R., Schauer R. Early diagnosis of clostridial gas gangrene using sialidase antibodies. Clin. Chim. Acta. 173:1988;251-262.
31. Roggentin T., Kleineidam R. G., Majewski D. M., Tirpitz D., Roggentin P., Schauer R. An immunoassay for the rapid and specific detection of three sialidase-producing clostridia causing gas gangrene. J. Immunol. Methods. 157:1993;125-133.
32. Rutishauser U., Watanabe M., Silver J., Troy F. A., Vimr E. R. Specific alteration of NCAM-mediated cell adhesion by an endoneuraminidase. J. Cell Biol. 101:1985;1842-1849.
33. Smith S. D., Shatsky M., Cohen P. S., Warnke R., Link M. P., Glader B. E. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44:1984;5657-5660.
34. Stamatos N. M., Gomatos P. J., Cox J., Fowler A., Dow N., Wohlhieter J. A., Cross A. S. Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1. Virology. 228:1997;123-131.
35. Steube K. G., Teepe D., Meyer C., Zaborski M., Drexler H. G. A model system in haematology and immunology: The human monocytic cell line MONO-MAC-1. Leukemia Res. 21:1997;327-335.
36. Taylor G. Sialidases: Structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 6:1996;830-837.
37. Ugolini S., Mondor I., Sattentau Q. J. HIV-1 attachment: Another look. Trends Microbiol. 7:1999;144-149.
38. Weiss A., Imboden J., Shoback D., Stobo J. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA. 81:1984;4169-4173.
39. Xin X., Shioda T., Fukushima M., Hu H., Oka S., Iwamoto A., Nagai Y. Facilitation of HIV-1 isolation from patients by neuraminidase. Arch. Virol. 143:1998;85-95.
40. Yee J. K., Miyanohara A., LaPorte P., Bouic K., Burns J. C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA. 91:1994;9564-9568.